3-(p-tolyl)furan | 20842-10-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(p-tolyl)furan
• 英文别名: 3-(4-Methylphenyl)furan
• CAS: 20842-10-8
• 化学式: C₁₁H₁₀O
• 分子量: 158.2
• InChiKey: PCWCERNFIYTAIK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  13.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-(p-tolyl)furan 在 吖啶 、 重水 、 palladium diacetate 、 2,4,6-triisopropyl-N-(quinolin-8-yl)benzamide 作用下， 以74 %的产率得到
  参考文献：
  名称：

  Palladium(II)‐Catalyzed Nondirected Late‐Stage C(sp2)–H Deuteration of Heteroarenes Enabled Through a Multi‐Substrate Screening Approach

  摘要：

  The importance of deuterium labelling in a variety of applications, ranging from mechanistic studies to drug‐discovery, has spurred immense interest in the development of new methods for its efficient incorporation in organic, and especially in bioactive molecules. The five‐membered heteroarenes at the center of this work are ubiquitous motifs in bioactive molecules and efficient methods for the deuterium labelling of these compounds are therefore highly desirable. However, the profound differences in chemical properties encountered between different heteroarenes hamper the development of a single set of broadly applicable reaction conditions, often necessitating a separate optimization campaign for a given type of heteroarene. In this study we describe the use of a multi‐substrate screening approach to identify optimal reaction conditions for different classes of heteroarenes from a minimal number of screening reactions. Using this approach, four sets of complementary reaction conditions derived from our dual ligand‐based palladium catalysts for nondirected C(sp2)–H activation were identified, that together enable the deuteration of structurally diverse heteroarenes, including bioactive molecules.

  DOI：

  10.1002/anie.202404421
• 作为产物：
  描述：

  4-(4-methylphenyl)furan-2(5H)-one 在 二异丁基氢化铝 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 2.0h， 以98%的产率得到3-(p-tolyl)furan
  参考文献：
  名称：

  Taniguchi, Takahiko; Nagata, Hiroshi; Kanada, Regina Mikie, Heterocycles, 2000, vol. 52, # 1, p. 67 - 71

  摘要：

  DOI：

文献信息

• [EN] SUBSTITUTED CYCLIC COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS CYCLIQUES SUBSTITUÉS ET PROCÉDÉS D'UTILISATION
  申请人：XI NING

  公开号：WO2013138210A1

  公开（公告）日：2013-09-19

  The present invention provides novel substituted cyclic compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.

  本发明提供了新颖的取代环化合物，药用可接受的盐及其制剂，用于调节蛋白酪氨酸激酶活性，并调节细胞活动，如增殖、分化、凋亡、迁移和侵袭。该发明还提供了包括这些化合物的药用可接受的组合物，以及在治疗哺乳动物，特别是人类的增生性疾病中使用这些组合物的方法。
• [EN] RODENTICIDAL NORBORMIDE ANALOGUES<br/>[FR] ANALOGUES DE NORBORMIDE RODENTICIDE
  申请人：LANDCARE RES NEW ZEALAND LTD

  公开号：WO2013133726A1

  公开（公告）日：2013-09-12

  The present invention relates to norbormide analogues having rodenticidal activity; rodenticidal compositions comprising the analogues; uses of the analogues as rodenticides; uses of the analogues in the manufacture of rodenticidal compositions; and methods for controlling rodents using the compositions.

  本发明涉及具有杀鼠活性的诺波酰胺类似物；包括这些类似物的杀鼠组合物；将这些类似物用作杀鼠剂的用途；将这些类似物用于制造杀鼠组合物的用途；以及使用这些组合物控制啮齿动物的方法。
• [EN] TASK CHANNEL ANTAGONISTS<br/>[FR] ANTAGONISTES DE CANAL TASK
  申请人：MERCK SHARP & DOHME

  公开号：WO2011103715A1

  公开（公告）日：2011-09-01

  This invention relates to TASK-1 and/or TASK-3 antagonists and/or their pharmaceutically acceptable salts, compositions and methods for treating and preventing disorders which are caused by activation or by an activated TASK-1 and/or TASK-3, and disorders which have TASK-1 and/or TASK-3-related damage as a secondary cause.

  这项发明涉及TASK-1和/或TASK-3拮抗剂及/或其药用盐、组合物和治疗以及预防由TASK-1和/或TASK-3的激活或被激活引起的疾病，以及由TASK-1和/或TASK-3相关损伤作为次要原因的疾病的方法。
• [EN] TASK CHANNEL ANTAGONISTS<br/>[FR] ANTAGONISTES DES CANAUX TASK
  申请人：MERCK SHARP & DOHME

  公开号：WO2011106276A1

  公开（公告）日：2011-09-01

  This invention relates to TASK-1 and/or TASK-3 antagonists and/or their pharmaceutically acceptable salts, compositions and methods for treating and preventing disorders which are caused by activation or by an activated TASK-1 and/or TASK-3, and disorders which have TASK-1 and/or TASK-3-related damage as a secondary cause.

  这项发明涉及TASK-1和/或TASK-3拮抗剂及/或其药用盐、用于治疗和预防由TASK-1和/或TASK-3的激活或被激活引起的疾病，以及由TASK-1和/或TASK-3相关损伤作为次要原因的疾病的组合物和方法。
• Suzuki–Miyaura Cross-Coupling Reaction with Potassium Aryltrifluoroborate in Pure Water Using Recyclable Nanoparticle Catalyst
  作者：Atsushi Ohtaka、Misa Kawase、Kyosuke Matsuoka、Tsutomu Shinagawa、Go Hamasaka、Yasuhiro Uozumi、Osamu Shimomura

  DOI：10.1055/a-1661-3152

  日期：2022.1

  the Suzuki–Miyaura cross-coupling reaction of aryl bromides with potassium aryltrifluoroborates in water catalyzed by linear polystyrene-stabilized PdO nanoparticles (PS-PdONPs). The reaction of aryl bromides having electron-withdrawing groups or electron-donating groups took place smoothly to give the corresponding coupling product in high yields. The catalyst recycles five times without significant

  本文描述了芳基溴化物与芳基三氟硼酸钾在线性聚苯乙烯稳定的 PdO 纳米粒子 (PS-PdONPS) 催化下在水中的 Suzuki-Miyaura 交叉偶联反应。具有吸电子基团或给电子基团的芳基溴化物反应顺利进行，以高产率得到相应的偶联产物。尽管在反应后观察到 PdNP 的尺寸略有增加，但催化剂循环五次而催化活性没有显着损失。